Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00214006 · ClinicalTrials.gov registry record

Carotid Atherosclerotic Plaque Study

A clinical trial of Atherosclerosis, sponsored by University of Wisconsin, Madison.

Completed
Registry status
162
Enrollment target
1
Study location

NCT00214006: Completed study of Atherosclerosis, sponsored by University of Wisconsin, Madison.

NCT00214006 is a study of Atherosclerosis that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 162 participants, below the 1,063-participant average among 69 other Atherosclerosis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00214006, a study of Atherosclerosis, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
162 participants
Enrollment target
1
Study location

Study Summary

First, to establish a comparison of the pathophysiology of carotid atherosclerosis and the genetic and environmental variables that cause those plaques to become symptomatic. Second, to differentiate between vulnerable plaque and other types of plaque using ultrasound elastography, MRI data, trans-cranial doppler along with RF (radio frequency) analysis of back-scattered ultrasonic echoes.

Primary Outcome

Comparison studies will be done using the lipid protein analysis and imaging studies. The primary comparison will be between those that are symptomatic and those that are asymptomatic. Secondary comparisons will be done using the lipid protein analysis and patient history. Comparison of cognitive status between groups will be made using analysis of covariance in which the difference in follow-up score between groups (symptomatic/asymptomatic) is adjusted for baseline score. The baseline adjuste

Conditions Studied

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2001-11
Est. Completion 2011-02
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00214006 record still lists

NCT00214006 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 1,063-participant average among 69 other Atherosclerosis trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Atherosclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00214006 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00214006 about?

NCT00214006 is a clinical study titled "Carotid Atherosclerotic Plaque Study". First, to establish a comparison of the pathophysiology of carotid atherosclerosis and the genetic and environmental variables that cause those plaques to become symptomatic. Second, to differentiate between vulnerable plaque and other types of plaque using ultrasound elastography, MRI data, trans-c...

What is the current status of trial NCT00214006?

This trial is currently completed. The enrollment target is 162 participants. The study started on 2001-11. Estimated completion is 2011-02.

What conditions does trial NCT00214006 study?

This clinical trial studies the following conditions: Atherosclerosis.

Who is sponsoring clinical trial NCT00214006?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00214006 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atherosclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00214006's enrollment target sits among peer trials

162 42nd of 69 higher than 28 of 69 other Atherosclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Atherosclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02347111 · 162 participants · Phase 4

    Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

  • NCT02610426 · 162 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

  • NCT05040711 · 162 participants · NA

    mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

  • NCT05514717 · 162 participants · Phase 1

    A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00214006, the US trial registry maintained by the National Library of Medicine. NCT00214006 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.